• Pulmatrix closed a private placement of Series B Convertible Preferred Stock with an affiliate of Eos SENOLYTIX as part of its planned merger with Eos.
• Series B Preferred Stock is convertible into Pulmatrix common stock at USD 2.20 per share.
• Gross proceeds were about USD 1 million.
• Net proceeds are earmarked for working capital.
• Securities, including underlying common shares, were sold in an unregistered offering.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pulmatrix Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NE39287) on April 21, 2026, and is solely responsible for the information contained therein.